๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetic Variation in IL28B: Impact on Drug Development for Chronic Hepatitis C Infection

โœ Scribed by Clark, P J; Thompson, A J V; McHutchison, J G


Book ID
109846075
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
117 KB
Volume
88
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


IL28B genetic variation and treatment re
โœ Amir Moghaddam; Espen Melum; Nils Reinton; Helmer Ring-Larsen; Hans Verbaan; Kri ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 325 KB ๐Ÿ‘ 2 views

Polymorphisms near the IL28B gene, which code for interferon (IFN)-ฮป3, predict response to pegylated interferon-ฮฑ (PEG-IFN) and ribavirin treatment in hepatitis C virus (HCV) genotype 1 infected patients. Follow-up studies of the effect of IL28B gene in HCV non-genotype 1 infected patients have almo

Impact of genetic polymorphisms near the
โœ Hidenori Toyoda; Takashi Kumada; Toshifumi Tada; Takahisa Kawaguchi; Yoshiki Mur ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 411 KB ๐Ÿ‘ 1 views

## Abstract It has been reported that genetic polymorphisms near the __IL28B__ gene or amino acid substitutions in hepatitis C virus (HCV) core protein are associated with the clinical outcome of peginterferon (PEGโ€IFN) and ribavirin combination therapy. The impact of these factors on the pure sens